TIDM0QCV TIDM0Y7T 
 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               AbbVie Inc. 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.01 common stock 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                27(th) April 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                69,965,244  4.73785% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  69,965,244  4.73785% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,500                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                                77                    84.33 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,665                    84.14 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                    84.03 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                               200                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                            97,790                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                            35,560                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                            43,758                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                            23,868                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                            11,925                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                             5,000                    84.15 
--------------  -----------------------------  ----------------------- 
   Purchase                               400                    84.03 
--------------  -----------------------------  ----------------------- 
   Purchase                               564                    84.69 
--------------  -----------------------------  ----------------------- 
   Purchase                               127                    84.48 
--------------  -----------------------------  ----------------------- 
   Purchase                             2,528                    84.15 
--------------  -----------------------------  ----------------------- 
     Sale                                 729                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                                 191                    84.39 
--------------  -----------------------------  ----------------------- 
     Sale                                 400                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                               1,700                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                              15,300                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                                 200                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                               1,432                    84.39 
--------------  -----------------------------  ----------------------- 
     Sale                                 812                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                               1,255                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                               1,530                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                                  99                    84.39 
--------------  -----------------------------  ----------------------- 
     Sale                               1,068                    84.69 
--------------  -----------------------------  ----------------------- 
     Sale                                 401                    84.39 
--------------  -----------------------------  ----------------------- 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       28(th) April 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 
-------------------------------------------------------  ----------------- 
If a connected EFM, state nature of connection (Note     N/A 
 10) 
-------------------------------------------------------  ----------------- 
 
 
 
 
 
 

(END) Dow Jones Newswires

April 28, 2020 09:52 ET (13:52 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Jul 2020 to Aug 2020 Click Here for more Allergan Charts.
Allergan (NYSE:AGN)
Historical Stock Chart
From Aug 2019 to Aug 2020 Click Here for more Allergan Charts.